TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01918345

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based Physical Activity Program with Health Coach
Description: This arm will receive either a trained CDE or R. Kin as a health coach and a home-based physical activity program for 6 months. Health coaches will provide one-on-one motivational interviewing (MI) and goal-setting, and will account for baseline fitness, resources, childcare, and breastfeeding, to be undertaken at participants' homes or in their communities. Prescriptions will be based on minimum recommendations for moderate-intensity exercise for postpartum women. Participants will maintain at least 150 min/week of moderate activity at a target heart rate of 30-80% with a perceived exertion of 12-15 on the Borg Scale. They will also be counseled on resistance training and pelvic floor exercises. They will receive regular telephone-based coaching to advance goals. Phone-calls will be administered on a weekly basis during weeks 2-8 of the intervention, biweekly basis on weeks 10-12, and monthly basis on weeks 16-24.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based Physical Activity Program with Health Coach
Description: This arm will receive either a trained CDE or R. Kin as a health coach and a home-based physical activity program for 6 months. Health coaches will provide one-on-one motivational interviewing (MI) and goal-setting, and will account for baseline fitness, resources, childcare, and breastfeeding, to be undertaken at participants' homes or in their communities. Prescriptions will be based on minimum recommendations for moderate-intensity exercise for postpartum women. Participants will maintain at least 150 min/week of moderate activity at a target heart rate of 30-80% with a perceived exertion of 12-15 on the Borg Scale. They will also be counseled on resistance training and pelvic floor exercises. They will receive regular telephone-based coaching to advance goals. Phone-calls will be administered on a weekly basis during weeks 2-8 of the intervention, biweekly basis on weeks 10-12, and monthly basis on weeks 16-24.
Study: NCT03466060

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Clear Care / RevitaLens : Opti-Free
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Clear Care / RevitaLens : Opti-Free
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Opti-Free / Clear Care : RevitaLens
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.
Study: NCT01918345

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based Low-GI Diet Program with Health Coach
Description: This arm will receive a trained CDE health coach and a home-based low-GI diet program for 6 months. Health coaches will provide baseline education during a one-on-one visit and use MI to introduce the dietary intervention. Low GI education will be layered on top of current standard care, which asks women to consume a diet comprised of 45-65% carbohydrates (25 g of dietary fibre), 10-30% protein, and 25-35% fat. As per standard care at the DEPs, this intake will be divided into 3 meals and 2 to 4 snacks. Resources for women will include a low GI dietary food substitution list, a recipe booklet, and a tip sheet on how to lower dietary GI. Women will receive regular telephone-based coaching to advance goals. Phone-calls will be administered on a weekly basis during weeks 2-8 of the intervention, biweekly basis on weeks 10-12, and monthly basis on weeks 16-24.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home-based Low-GI Diet Program with Health Coach
Description: This arm will receive a trained CDE health coach and a home-based low-GI diet program for 6 months. Health coaches will provide baseline education during a one-on-one visit and use MI to introduce the dietary intervention. Low GI education will be layered on top of current standard care, which asks women to consume a diet comprised of 45-65% carbohydrates (25 g of dietary fibre), 10-30% protein, and 25-35% fat. As per standard care at the DEPs, this intake will be divided into 3 meals and 2 to 4 snacks. Resources for women will include a low GI dietary food substitution list, a recipe booklet, and a tip sheet on how to lower dietary GI. Women will receive regular telephone-based coaching to advance goals. Phone-calls will be administered on a weekly basis during weeks 2-8 of the intervention, biweekly basis on weeks 10-12, and monthly basis on weeks 16-24.
Study: NCT02687880

Intervention type: PROCEDURE
Intervention: Testicular biopsy
Description: Subjects will undergo a surgical procedure to harvest their testicular tissue.
Study: NCT00509197

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (sham inhaler)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasone
Description: Fluticasone 250mcg bid for one month
Study: NCT04167397

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collaborative learning
Description: Participants will be allocated to either single, dyad, triad or tetrad practice during initials skills training on an ultrasound simulator. Afterwards their competencies will be assessed with an individual transfer test on another simulator.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collaborative learning
Description: Participants will be allocated to either single, dyad, triad or tetrad practice during initials skills training on an ultrasound simulator. Afterwards their competencies will be assessed with an individual transfer test on another simulator.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collaborative learning
Description: Participants will be allocated to either single, dyad, triad or tetrad practice during initials skills training on an ultrasound simulator. Afterwards their competencies will be assessed with an individual transfer test on another simulator.
Study: NCT03188549

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Softa-Man (Braun)
Description: Hand hygiene formula

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Septol
Description: alcohol-based hand rub
Study: NCT04167397

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Collaborative learning
Description: Participants will be allocated to either single, dyad, triad or tetrad practice during initials skills training on an ultrasound simulator. Afterwards their competencies will be assessed with an individual transfer test on another simulator.
Study: NCT01969838

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Momelotinib
Description: Momelotinib tablet administered orally once daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ruxolitinib
Description: Ruxolitinib tablets administered orally twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo to match momelotinib
Description: Placebo to match momelotinib tablets administered orally once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to match ruxolitinib
Description: Placebo to match ruxolitinib tablets administered orally twice daily
Study: NCT05395377

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Registered Dietitian/Nutritionist
Description: Participants received a FitBit Flex and Intensive Lifestyle Intervention coaching via telephone with Registered Dietitian/Nutritionist.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diabetes Prevention Program
Description: Modified DPP group classes lead by a Registered Dietitian and Exercise Physiologist.
Study: NCT03466060

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Opti-Free / Clear Care : RevitaLens
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Opti-Free / Clear Care : RevitaLens
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Opit-Free / RevitaLens : Clear Care
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Opit-Free / RevitaLens : Clear Care
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RevitaLens : Opit-Free / RevitaLens : Clear Care
Description: Subjects between the ages of 18-69 will be randomized to 1 of 3 lenses. Solutions will be administered contralaterally with 1 test solution and 1 of 2 control solutions prior to the subjects' follow-up visits.
Study: NCT02854722

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deferasirox and calcium-vitamin D3
Description: deferasirox and calcium-vitamin D3 Deferasirox is an orodispersible tablet and should be taken daily 30 minutes before breakfast, with a dose of 10 mg/Kg/day ± 5 mg/Kg/day during 12 month.~Calcium 500 mg and vitamin D3 800 IU should also be taken daily as a basic therapy.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Calcium-vitamin D3
Description: Calcium 500 mg and vitamin D3 800 IU are taken daily as a basic therapy.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calcium-vitamin D3
Description: Calcium 500 mg and vitamin D3 800 IU are taken daily as a basic therapy.
Study: NCT05395377

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weight Watchers, Reimagined
Description: Participants in this group were provided with an online access code to enroll in WW and could choose the format of their choice- group, online, and/or smartphone app.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: DPP or RDN Counseling + Medication
Description: Participants met with a weight management specialist to receive weight loss medications, as well as, receiving either the DPP or Registered Dietitian coaching. Medications utilized in this study were Phentermine and Metformin. Metformin was prescribed if the participant could not tolerate Phentermine.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Bariatric Surgery Evaluation
Description: Participants (BMI \> 40) were offered a consultation with the bariatric surgical program that requires lifestyle weight management during the first 6 months. Participants were also able to choose to receive one of the other 4 intervention options in the first six months prior to consideration for bariatric surgery.
Study: NCT02241226

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Perfect Health Course
Description: The Perfect Health course as taught at the Chopra Center for Wellbeing
Study: NCT04489095

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Electrophysiology Study
Description: After informed consent is obtained, patient will undergo TAVR as per usual standard of care. Using the same femoral vein access as is used standard for a portion of the TAVR procedure, an EPS will be performed during the TAVR procedure, immediately before and after valve implantation. The patient will recover on a general telemetry floor as per usual care, and the next day will undergo another EPS. This is not uncommonly done clinically for some patients after TAVR. At that point, based on the baseline EKG, intra-procedure findings, and EPS findings, the patient will either have a pacemaker implanted, a 30-day event monitor ordered, or neither of the above.
Study: NCT01347021

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sacrospinous colpopexy versus high uterosacral colpopexy
Description: Women with uterine prolapse grade III or IV were randomly allocated to the sacrospinous colpopexy or high uterosacral colpopexy with vaginal hysterectomy.Before the surgery P-Qol questionnaire were completed and urogynecological examination include de POP-Q system was done. All patients underwent clinical check-ups 1, 6 and 12 months postoperatively. Each check-up included clinical examination and questionnaire.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sacrospinous colpopexy versus high uterosacral colpopexy
Description: Women with uterine prolapse grade III or IV were randomly allocated to the sacrospinous colpopexy or high uterosacral colpopexy with vaginal hysterectomy.Before the surgery P-Qol questionnaire were completed and urogynecological examination include de POP-Q system was done. All patients underwent clinical check-ups 1, 6 and 12 months postoperatively. Each check-up included clinical examination and questionnaire.
Study: NCT01892475

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentive-based physical activity program
Description: Drivers will be offered rewards valued at a day's rental for meeting daily step targets over the specified number of days each month from Months 1 to 4, where steps will be tracked by a step counter. They will also be offered incentives for meeting the following criteria:~1. Accurately predicting step target attainment the following months (SGD10)~2. Wearing and providing step data over the month (SGD10 and a chance to win 1 of 3 cash prizes valued at SGD500)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Incentive-based physical activity program
Description: Drivers will be offered rewards valued at a day's rental for meeting daily step targets over the specified number of days each month from Months 1 to 4, where steps will be tracked by a step counter. They will also be offered incentives for meeting the following criteria:~1. Accurately predicting step target attainment the following months (SGD10)~2. Wearing and providing step data over the month (SGD10 and a chance to win 1 of 3 cash prizes valued at SGD500)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 3-month follow up
Description: After the 4-month RCT, drivers will be incentivized to wear the step counter for another 3 months (i.e. Months 5 to 7) to test if effects of the rewards are sustained once the reward is no longer in place. For wearing their step counter and providing their step data, drivers will receive a modest cash incentive (amounting to SGD10) each month as well as the chance to win 1 of 3 cash prizes valued at SGD500.
Study: NCT00308100

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxyethylstarch 130/0.4
Description: HES 130/0.4, administered intra- and perioperatively, max. daily dose: 33ml/kg BW; if needed, additionally albumin is administered (ratio crystalloid to colloid= 1:1)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5% Albumin
Description: 5% albumin, administered intra- and perioperatively
Study: NCT01892475

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 3-month follow up
Description: After the 4-month RCT, drivers will be incentivized to wear the step counter for another 3 months (i.e. Months 5 to 7) to test if effects of the rewards are sustained once the reward is no longer in place. For wearing their step counter and providing their step data, drivers will receive a modest cash incentive (amounting to SGD10) each month as well as the chance to win 1 of 3 cash prizes valued at SGD500.
Study: NCT00927745

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AutoFlow mode on Evita 4 Dräger ventilators
Description: Activation of AutoFlow mode during assist-controlled ventilation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Evita 4 Dräger ventilators
Description: Assist-controlled ventilation without activation of AutoFlow mode
Study: NCT02680691

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Robot, then conventional training
Description: Robot assisted gait training from the baseline, then conventional gait training at 4 weeks after baseline

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional, then robot training
Description: Conventional gait training from the baseline, then robot assisted gait training at 4 weeks after baseline
Study: NCT06146244

Intervention type: PROCEDURE
Intervention: sinus lift
Description: Implant placement on grafted sinus vs antral autogenous bone

Intervention type: DEVICE
Intervention: resonance frequency analysis
Description: analysis of the ISQ evolution and its changes after 3 months of placing the implant in native or regenerated bone, always in the antral area

Intervention type: DEVICE
Intervention: resonance frequency analysis
Description: analysis of the ISQ evolution and its changes after 3 months of placing the implant in native or regenerated bone, always in the antral area
Study: NCT01961635

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dental implants
Description: place implant according fabricant guidelines, 2mm sub-crestally
Study: NCT01546415

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Desferasirox
Description: Initial Dose: 20 mg/kg/d. Dose modification according to protocol.
Study: NCT01975844

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized Anemia Mangement Protocol
Description: Phase 1 (1-3 months): Develop individualized patient models and Anemia Management Protocols (AMP) while patients are receiving standard medical care.~Phase 2 (9 months): Individualized AMP study period. Phase 3 (9 months): Follow up period: return to standard-care AMP .
Study: NCT02081794

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored education intervention
Description: Receive 2 minute video-assisted intervention on the risk and prevention of falls with tailored hand-outs depending on participant answers about fall risks

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard fall care
Description: Patient are given a generic handout on falling and receive standard care by nurses comprising of a fall risk assessment and verbal education
Study: NCT04321837

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Coral Complex 3
Description: Coral-derived calcium supplement fortified with vitamin D3

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Coral Complex 3
Description: Coral-derived calcium supplement fortified with vitamin D3

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibandronate
Description: Bisphosphonate

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ibandronate
Description: Bisphosphonate

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D3
Description: Oral vitamin D3
Study: NCT01049555

Intervention type: OTHER
Group type: OTHER
Intervention: Actigraphy and video recording signal
Description: Actigraphy and video recording signal during 1 hour

Intervention type: OTHER
Group type: OTHER
Intervention: Actigraphy and video recording signal
Description: Actigraphy and video recording signal during 1 hour

Intervention type: OTHER
Group type: OTHER
Intervention: Actigraphy and video recording signal
Description: Actigraphy and video recording signal during 1 hour
Study: NCT01961635

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dental implants
Description: place implant according fabricant guidelines, 2mm sub-crestally

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dental implants
Description: place implant according fabricant guidelines, 2mm sub-crestally

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Zirconia abutments
Description: place zirconia abutment on the day of implant placement

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Titanium Abutments
Description: place titanium abutment on the day of implant placement

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: cad-cam acrylic abutments
Description: place cad-cam acrylic abutment on the day of implant placement

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subcrestal
Description: place implant 2mm below crestal bone

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subcrestal
Description: place implant 2mm below crestal bone

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subcrestal
Description: place implant 2mm below crestal bone

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: platform-switch
Description: abutment platform is narrow than implant diameter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: platform-switch
Description: abutment platform is narrow than implant diameter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: platform-switch
Description: abutment platform is narrow than implant diameter

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: one-time one-abutment
Description: place the final abutment on the day of surgery and not remove it

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: one-time one-abutment
Description: place the final abutment on the day of surgery and not remove it

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: one-time one-abutment
Description: place the final abutment on the day of surgery and not remove it

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Torque 20 n/cm2
Description: the amount of torque applied to the abutment

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Torque 20 n/cm2
Description: the amount of torque applied to the abutment

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Torque 20 n/cm2
Description: the amount of torque applied to the abutment